COST-EFFECTIVENESS OF THE DENGUE VACCINE TAK-003 IN THAILAND

被引：0
|
作者：
Shen, J. [1 ]
Kharitonova, E. [2 ]
Biswal, S. [3 ]
Sharma, M. [3 ]
Aballea, S. [2 ]
Tytula, A. [4 ]
Zawieja, J. [4 ]
Towle, P. [1 ]
Hanley, R. [1 ]
Rungmaitree, S. [5 ]
机构：
[1] Takeda Pharmaceut Int AG, Zurich, Switzerland
[2] Putnam PHMR, Paris, France
[3] Takeda Vaccines Inc, Cambridge, MA USA
[4] Putnam PHMR, Krakow, Poland
[5] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE562
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [31] GRADE 3 SOLICITED AND UNSOLICITED ADVERSE EVENTS (AES) FOLLOWING VACCINATION WITH TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003)
    Ismail, E.
    Tricou, V.
    Folschweiller, N.
    Lloyd, E.
    Rauscher, M.
    Biswal, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S105 - S105
  • [32] Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines
    Shim, Eunha
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (05): : 1137 - 1147
  • [33] COST OF DENGUE ILLNESS AND COST-EFFECTIVENESS OF THE CDY-TDV DENGUE VACCINE IN ECUADOR
    Lucio-Romero, R.
    Henriquez-Trujillo, A. R.
    Bermudez-Gallegos, K.
    Tello-Ponce, B.
    Caicedo, Navas A. G.
    Vandeputte, C.
    VALUE IN HEALTH, 2016, 19 (07) : A416 - A416
  • [34] Travel medicine providers' opinions on the dengue vaccine TAK-003 as a travel vaccine and the need for decision-support information and materials before its launch in Japan
    Fukunishi, Atsuko
    Machida, Masaki
    Fukushima, Shinji
    Inoue, Shigeru
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [35] Consistency of immunogenicity in three consecutive lots of a tetravalent dengue vaccine candidate (TAK-003): A randomized placebo-controlled trial in US adults
    Tricou, Vianney
    Winkle, Peter J.
    Tharenos, Leslie M.
    Rauscher, Martina
    Escudero, Ian
    Hoffman, Elaine
    LeFevre, Inge
    Borkowski, Astrid
    Wallace, Derek
    VACCINE, 2023, 41 (47) : 6999 - 7006
  • [36] Safety signal detected: Anaphylaxis after attenuated dengue vaccine (TAK-003) - Brazil, march 1, 2023-march 11, 2024
    Percio, Jadher
    Kobayashi, Carla Dinamerica
    Silva, Roberta Mendes Abreu
    Marinho, Ana Karolina Barreto Berselli
    Capovilla, Leon
    Andrade, Paulo Henrique Santos
    da Nobrega, Martha Elizabeth Brasil
    Cabral, Cibelle Mendes
    de Moraes, Monica Brauner
    Werneck, Guilherme Loureiro
    Fernandes, Eder Gatti
    VACCINE, 2024, 42 (26)
  • [37] A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
    Ghezzi, Benedetta
    Valencia, Cristina
    de Oliveira, Roberto Dias
    Tsuha, Daniel
    Lucena Junior, Waldno
    Di Pasquale, Alberta
    Mc Namara, Morgan
    Senra, Juliana
    Abud, Denise
    Croda, Julio
    VACCINES, 2025, 13 (02)
  • [38] IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial
    Low, Jenny G.
    Oh, Helen M.
    Leo, Yee-Sin
    Kalimuddin, Shirin
    Wijaya, Limin
    Pang, Junxiong
    Lee, Tau Hong
    Moss, Kelley J.
    Brose, Manja
    Tricou, Vianney
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2024, 111 (01): : 102 - 106
  • [39] A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country
    Tricou, Vianney
    Eyre, Susannah
    Ramjee, Mahadev
    Mojares, Zenaida
    Collini, Paul
    Loeliger, Edde
    Mandaric, Sanja
    Rauschera, Martina
    Brose, Manja
    Lefevre, Inge
    Folschweiller, Nicolas
    Wallace, Derek
    VACCINE, 2023, 41 (07) : 1398 - 1407
  • [40] Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study
    Tricou, Vianney
    Essink, Brandon
    Ervin, John E.
    Turner, Mark
    Escudero, Ian
    Rauscher, Martina
    Brose, Manja
    Lefevre, Inge
    Borkowski, Astrid
    Wallace, Derek
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (03):
12345